Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)
Clinical trial NCT04990388 · TERMINATED
Trial details
- NCT number
- NCT04990388
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2023-03-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.